| Brand Name | Braftovi |
| Packaging Type | Box |
| Molecule | Encorafenib |
| Generic Name | Encorafenib |
| Manufactured By | Array BioPharma Inc |
| Quantity | 42 Capsules |
| Form | Capsule |
| Country of Origin | United States |
| Categories | Oncology |
Braftovi (Encorafenib 75 mg Capsules) is a potent BRAF inhibitor used in combination with binimetinib for the treatment of patients with unresectable or metastatic melanoma with a BRAF V600E or V600K mutation, as detected by an FDA-approved test. Encorafenib targets the mutated BRAF protein, inhibiting its activity and thereby slowing the growth and spread of melanoma cells. This targeted therapy offers an effective treatment option for patients with specific genetic profiles, enhancing survival rates and quality of life. Our super specialty pharmacy provides high-quality Braftovi with personalized treatment plans and expert support to ensure optimal care for melanoma patients. Trust us for comprehensive and effective cancer care tailored to your specific needs.
